Medicines for Malaria Venture   Report issue

Foundation Phase 1 Phase 2 Phase 3 Phase 4
Founded: Geneva Switzerland (1999)

Organization Overview

First Clinical Trial
2005
NCT01594931
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Medicine for Malaria Venture | Medicines for Malaria Ventire | Medicines for Malaria Venture | Medicines for Malaria Venture (MMV) | Medicines for Malaria Venture (MMV), Switzerland | MMV | MMV Medicines for Malaria Venture

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 3)

Communicable Diseases (Phase 1)

Hemolysis (Phase 3)

Infections (Phase 1)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Malaria, Vivax (Phase 3)

Parasitemia (Phase 1)

Parasitic Diseases (Phase 1)

Protozoan Infections (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 86
  • # of Trial APIs: 49